Moreover, AML cells can upregulate inhibitory ligands that bind to the checkpoint receptors in CAR-T cells, such as PD-1, TIM-3, CTLA-4, TIGIT, and GITR, and prevent their function by inducing exhaustion or anergy [57,58,59,60,61]. Here, TIGIT is linked to acute myeloid leukemia.